Francesca Prignano

Prof. Dr. Francesca Prignano

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Autoimmunity Reviews
Verified
Journal Article
Closed access
FCFabrizio Cantini
Fabrizio Cantini
CNCarlotta Nannini
Carlotta Nannini
LNLaura Niccoli
Laura Niccoli
Florenzo IannoneFlorenzo Iannone
Florenzo Iannone
GDGiovanni Delogu
Giovanni Delogu
DELIA GOLETTIDELIA GOLETTI
DELIA GOLETTI

19 December 2024 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
Christos C. ZouboulisChristos C. Zouboulis
Christos C. Zouboulis
FBFalk G. Bechara
Falk G. Bechara
FBF. Benhadou
F. Benhadou
VBVincenzo Bettoli
Vincenzo Bettoli
ZMZ. Bukvić Mokos
Z. Bukvić Mokos
GJG. B. E. Jemec
G. B. E. Jemec
Introduction: This second part of the S2k guidelines is an update of the 2015 S1 European guidelines.Objective: These guidelines aim to provide an accepted decision aid for the selection, implementation and assessment of appropriate and sufficient therapy for patients with hidradenitis suppurativa/acne inversa (HS).Methods: The chapters have been selected after a Delphi procedure among the experts/authors. Certain passages have been adopted without changes from the previous version. Potential treatment complications are not included, being beyond the scope of these guidelines.Results: Since the S1 guidelines publication, validation of new therapeutic approaches has almost completely overhauled the knowledge in the field of HS treatment. Inflammatory nodules/abscesses/draining tunnels are the primary lesions, which enable the classification of the disease severity by new validated tools. In relation to the degree of detectable inflammation, HS is classified into the inflammatory and the predominantly non‐inflammatory forms. While the intensity of the inflammatory form can be subdivided by the IHS4 classification in mild, moderate and severe HS and is treated by medication accordingly, the decision on surgical treatment of the predominantly non‐inflammatory form is based on the Hurley stage of the affected localization. The effectiveness of oral tetracyclines as an alternative to the oral combination of clindamycin/rifampicin should be noted. The duration of systemic antibiotic therapy can be shortened by a 5‐day intravenous clindamycin treatment. Adalimumab, secukinumab and bimekizumab subcutaneous administration has been approved by the EMA for the treatment of moderate‐to‐severe HS. Various surgical procedures are available for the predominantly non‐inflammatory form of the disease. The combination of a medical therapy to reduce inflammation with a surgical procedure to remove irreversible tissue damage is currently considered a holistic therapeutic approach.Conclusions: Suitable therapeutic options while considering HS severity in the therapeutic algorithm according to standardized criteria are aimed at ensuring a proper therapy.

2 March 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
Angelo MarzanoAngelo Marzano
Angelo Marzano
GGGiovanni Genovese
Giovanni Genovese
GCGiovanni Casazza
Giovanni Casazza
Chiara MoltrasioChiara Moltrasio
Chiara Moltrasio
PDP. Dapavo
P. Dapavo
KPK. Peris
K. Peris

27 February 2017 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
PGPaolo Gisondi
Paolo Gisondi
GAG. Altomare
G. Altomare
FAF. Ayala
F. Ayala
FBF. Bardazzi
F. Bardazzi
LBLuca Bianchi
Luca Bianchi
GGG. Girolomoni
G. Girolomoni
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, appropriate use of therapeutic resources is very important. Management of psoriasis in daily clinical practice is highly variable because many issues are still debated and not definitely addressed by the evidence‐based medicine. Moreover, the different availability and reimbursability of drugs in each country justifies national guidelines. Expert consensus can provide helpful guidelines for optimizing patient care. A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications for systemic treatments, the parameters to be considered in the choice of treatment, and the factors to be considered in the choice of biological treatment. The recommendations for the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatology and Venereology psoriasis guidelines. Recommendations on the treatment of psoriasis in special patient populations were also agreed. The final document was discussed in a meeting moderated by a facilitator with participation of the entire group and adopting a nominal group technique to reach consensus. A statement was regarded as consented when agreement was achieved by at least 75% of the voting experts according to the Delphi procedure.

1 November 2009 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
FPFrancesca Prignano
Francesca Prignano
PCP. Campolmi
P. Campolmi
PBP. Bonan
P. Bonan
FRF. Ricceri
F. Ricceri
GCG. Cannarozzo
G. Cannarozzo
TLT. Lotti
T. Lotti

1 January 2008 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
TLTorello Lotti
Torello Lotti
GBGionata Buggiani
Gionata Buggiani
FPFrancesca Prignano
Francesca Prignano
Emotional tensions in predisposed subjects may play a key role in inducing a pruritic sensation, leading to a scratching that, becoming a self-perpetuating pathomechanism, may represent the main feature of two distinct cutaneous clinical entities: prurigo nodularis and lichen simplex chronicus. Psychogenic factors play a relevant role in both conditions, and they are often associated with depression and dissociative experiences. Hence, the importance of the evaluation of these patients from the point of view of psychodermatology, which may analyze the relationship between skin disease and psychological factors. Patients with real or perceived imperfections in particular areas of the body (face, scalp, hands, and genital area) are more prone to psychologic distress, whereas cutaneous diseases may lead to experience a heightened level of distress. As psychosomatic factors have been estimated to be present in at least one-third of dermatologic patients, effective management of skin conditions involves consideration of the associated emotional factors.